BMC Medical Co., Ltd. (SHE:301367)

BMC Medical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	1,010	1,071	524.57	670.35	356.11	113.94
Short-Term Investments	-	-	-	40.05	-	-
Trading Asset Securities	1,613	1,515	2,286	1,812	2,160	295
Cash & Short-Term Investments	2,623	2,586	2,810	2,523	2,516	408.94
Cash Growth	-8.76%	-7.98%	11.39%	0.27%	515.27%	19.48%
Accounts Receivable	248.04	241.77	186.46	127.68	102.94	31.71
Other Receivables	4.7	4.51	4.86	3.9	2.02	1.03
Receivables	252.74	246.28	191.32	131.59	104.96	32.74
Inventory	209.15	115.79	102.41	118.01	203.31	117.22
Other Current Assets	107.59	112.03	31.77	18.32	24.53	30.55
Total Current Assets	3,192	3,060	3,136	2,791	2,849	589.46
Property, Plant & Equipment	48.24	42.48	47.07	60.04	47.64	17.02
Long-Term Investments	257.51	214.21	213.73	42.74	-	5.19
Other Intangible Assets	31.51	34.03	5.87	6.3	8.11	2.5
Long-Term Deferred Tax Assets	18.2	15.51	6.29	3.56	6.17	1.39
Long-Term Deferred Charges	12.47	12.22	7.74	10.71	8.26	5.34
Other Long-Term Assets	26.69	6.54	8.34	4.41	7.67	2.79
Total Assets	3,587	3,385	3,425	2,919	2,927	623.69

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	211.41	138.67	85.94	39.73	103.26	68.83
Accrued Expenses	25.17	43.69	29.61	26.76	44.3	24.71
Short-Term Debt	179.46	75.85	384.51	-	-	-
Current Portion of Leases	-	5.33	10.3	10.35	3.72	1.57
Current Income Taxes Payable	23.66	12.42	3.17	3.63	20.86	1.3
Current Unearned Revenue	32.13	23.45	37.79	27.94	102.6	26.89
Other Current Liabilities	29.69	38.84	27.31	3.85	14.64	5.17
Total Current Liabilities	507.97	338.24	578.63	112.25	289.38	128.48
Long-Term Leases	6.73	2.83	8.13	16.4	17.34	2.54
Long-Term Unearned Revenue	-	-	-	-	-	0.54
Long-Term Deferred Tax Liabilities	0.24	0.32	0.53	0.74	1.5	-
Other Long-Term Liabilities	-	-	-	2.23	1.44	0.86
Total Liabilities	514.94	341.39	587.28	131.62	309.66	132.41

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	125.28	89.6	89.6	64	64	48
Additional Paid-In Capital	1,729	1,761	1,747	1,773	1,773	50.56
Retained Earnings	1,292	1,224	1,034	942.47	773.13	392.72
Treasury Stock	-86.75	-44.28	-42.26	-	-	-
Comprehensive Income & Other	0.61	0.5	-0.16	-0	-	-
Total Common Equity	3,059	3,031	2,828	2,779	2,610	491.28
Minority Interest	12.83	12.66	9.26	7.64	7.15	-
Shareholders' Equity	3,072	3,044	2,838	2,787	2,617	491.28
Total Liabilities & Equity	3,587	3,385	3,425	2,919	2,927	623.69

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	192.64	84.01	402.94	26.75	21.06	4.11
Net Cash (Debt)	2,430	2,502	2,407	2,496	2,495	404.83
Net Cash Growth	-2.31%	3.93%	-3.56%	0.04%	516.32%	18.28%
Net Cash Per Share	19.55	20.12	19.26	19.91	25.14	4.31
Filing Date Shares Outstanding	123.07	124.42	124.47	125.44	125.44	94.08
Total Common Shares Outstanding	123.07	124.42	124.47	125.44	125.44	94.08
Working Capital	2,684	2,722	2,557	2,679	2,560	460.98
Book Value Per Share	24.86	24.36	22.72	22.16	20.81	5.22
Tangible Book Value	3,028	2,997	2,822	2,773	2,602	488.77
Tangible Book Value Per Share	24.60	24.09	22.68	22.11	20.74	5.20
Machinery	-	75.81	65.04	62.25	47.51	29.05

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 13, 2026

Data Sources Report a data error